Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Increased risk of tramadol adverse effects
Management
If coadministering, consider decreasing tramadol dose when coadministering. Titrate to clinical effect and monitor for sedation.
Info Source
